AC Immune financials at a glance

+ Portfolio

The revenue of AC Immune is reported as 0.0148 billion Dollars in the fiscal year 2023. The earnings were -0.64 Dollars per share in 2023, which was 20.99 higher than 2022. And about -0.06131 billion Dollars are reported as free cash flow in the financials of AC Immune 2023. No dividends were paid to the shareholders of the AC Immune stock NasdaqGM:ACIU in the financial year 2023.

$14.80M

Revenue

$-0.64

Earnings Per Share

-,268.93%

Gross Margin %

$-77.80M

Free Cash Flow

Revenue

14.80

Earnings Per Share

-0.64

Gross Margin %

-,268.93

Free Cash Flow

-77.80

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018	2017	2016	2015
Rev.	Revenue	N/A	$14.80M	$3.94M	$0.00M	$15.43M	$111.03M	$7.20M	$20.30M	$23.20M	$0.00M
GM %	Gross Margin %	0.00%	-,268.93%	0.00%	0.00%	-,285.50%	54.34%	0.00%	-61.26%	-11.03%	0.00%
OM	Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%	40.32%	0.00%	-,111.28%	-45.04%	0.00%
EPS	Earnings Per Share	$-0.81	$-0.64	$-0.81	$-0.99	$-0.79	$0.64	$-0.76	$-0.46	$-0.14	$0.44
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	0	-0.00%	0.00%	-0.00%	-0.00%	-0.00%	0
Sha.	Shares	N/AM	93.95M	77.41M	77.26M	67.7M	71.86M	67.56M	57.36M	56.92M	46.4M
OCF	Operating Cash Flow	N/A	$-60.41M	$-73.57M	$-65.69M	$-59.52M	$55.22M	$-44.08M	$-22.09M	$-5.65M	$0.00M
FCF	Free Cash Flow	N/A	$-77.80M	$-74.81M	$-68.32M	$-61.22M	$53.33M	$-45.94M	$-23.90M	$-6.55M	$0.00M
FCFS	Free Cash Flow Per Share	$-0.74	$-0.72	$-0.90	$-0.91	$-0.85	$0.76	$-0.74	$-0.42	$-0.13	$0.00

AC Immune financials at a glance

Financials

Discover